Cardiac Troponins and High-Sensitivity Assays

Cardiac troponins are regulatory proteins of the cardiac contractile apparatus whose appearance in the blood is the most cardiac-specific available indicator of myocardial injury. High-sensitivity assays now measure them at concentrations present even in healthy people, making troponin the analyte at the centre of the biochemical definition of myocardial injury and infarction.

Definition

Cardiac troponins are the cardiac-specific isoforms of the troponin I and troponin T subunits of the troponin regulatory complex that governs calcium-dependent actin-myosin interaction in striated muscle; their release into the circulation reflects cardiomyocyte injury, and they are quantified by immunoassay against the 99th-percentile upper reference limit.

Scope

This topic covers the molecular biology of the cardiac troponin complex, the isoforms cardiac troponin I and cardiac troponin T, their release kinetics after myocardial injury, the 99th-percentile reference limit, and what 'high-sensitivity' means analytically. It treats troponin as a clinical-biochemistry analyte; diagnostic algorithms and rule-out protocols are referenced as evidence rather than offered as clinical instructions.

Core questions

• What distinguishes a high-sensitivity troponin assay from an earlier-generation assay?
• How do cardiac troponin I and troponin T differ as analytes?
• Why does the definition of injury rely on serial change rather than a single value?
• What non-coronary conditions raise troponin, and why?
• How does the 99th-percentile reference limit determine what counts as elevation?

Key concepts

• Troponin complex (TnC, TnI, TnT)
• Cardiac troponin I (cTnI) and troponin T (cTnT)
• 99th-percentile upper reference limit
• Coefficient of variation at the reference limit (analytical imprecision)
• High-sensitivity assay (detection in most healthy individuals)
• Release kinetics and serial sampling
• Delta (rise or fall) interpretation
• Cardiac versus non-cardiac troponin elevation

Mechanisms

Troponin is a three-subunit complex (troponin C, troponin I, troponin T) bound to the thin filament of striated muscle, where it regulates calcium-triggered actin-myosin interaction. The troponin I and troponin T subunits have cardiac-specific isoforms encoded by distinct genes, which gives cardiac troponin its tissue specificity. When cardiomyocytes are injured, troponin is released into the circulation — initially from a small cytosolic pool, then more durably as the structural pool degrades — producing a rise-and-fall pattern over hours to days. Because the contractile-apparatus pool is large and clearance is comparatively slow, troponin remains detectable longer than older necrosis markers. High-sensitivity assays lower the limit of detection enough to quantify troponin in the majority of healthy individuals with acceptable imprecision at the 99th percentile, which shifts interpretation toward the reference limit and the magnitude of serial change.

Clinical relevance

Cardiac troponin is the analyte the Universal Definition of Myocardial Infarction places at the centre of the biochemical definition of injury, and understanding its kinetics and specificity is essential to interpreting cardiac investigations critically. This entry describes the biology and analytics of troponin as evidence; it does not provide diagnostic cut-offs, rule-out timing, or treatment guidance for individual patients.

Epidemiology

Troponin is among the most frequently measured analytes in acute care, and high-sensitivity assays detect quantifiable troponin in the large majority of the general population, which is why population-based 99th-percentile reference limits and sex-specific limits are central to its interpretation.

Evidence & guidelines

The Fourth Universal Definition of Myocardial Infarction (Thygesen et al., 2018) defines myocardial injury by troponin above the 99th-percentile reference limit and infarction by injury with ischaemia. Cohort studies of sensitive and high-sensitivity assays (Reichlin et al., 2009; Than et al., 2012) and analytical characterisations (Apple & Collinson, 2012) describe how lower detection limits change measurement, while expert consensus (Newby et al., 2012) addresses interpretation of elevations.

History

Cardiac troponin assays entered clinical biochemistry in the 1990s and rapidly displaced creatine kinase-MB as the preferred necrosis marker because of their cardiac specificity. The successive Universal Definition of Myocardial Infarction documents codified troponin's central role, and the introduction of high-sensitivity assays in the early 2010s lowered detection limits enough to reshape how low-level elevations and serial changes are interpreted.

Debates

Should troponin reference limits be sex-specific?

High-sensitivity assays reveal lower 99th-percentile concentrations in women than in men, raising the question of whether sex-specific reference limits should replace a single overall limit; the balance of benefit remains an active methodological discussion.

How should non-coronary troponin elevations be interpreted?

Because troponin reports injury rather than its cause, elevations occur in many non-coronary conditions, so distinguishing acute coronary injury from chronic or secondary elevation depends on serial change and clinical context rather than the analyte alone.

Key figures

• Kristian Thygesen
• Allan S. Jaffe
• Fred S. Apple
• Christian Mueller

Seminal works

• thygesen-2019
• reichlin-2009
• apple-2012

Frequently asked questions

What does 'high-sensitivity' troponin mean?

A high-sensitivity assay can measure troponin at much lower concentrations than earlier assays, detecting it in most healthy people with acceptable analytical precision at the 99th-percentile reference limit; this shifts interpretation toward small concentrations and serial change rather than a simple positive-or-negative result.

Does a raised troponin always mean a heart attack?

No. Troponin indicates that cardiomyocytes have been injured, but injury can arise from many conditions besides coronary occlusion; the Universal Definition reserves the term myocardial infarction for injury accompanied by evidence of ischaemia, which is why serial measurement and clinical context matter.